Patents Assigned to Vaxxinova US, Inc.
  • Proteins and immunizing compositions containing proteins and methods of use
    Patent number: 12233120
    Abstract: The present invention provides isolated proteins isolatable from a Pasteurella spp. such as P. multocida. Also provided by the present invention are compositions that include one or more of the proteins, and methods for making and methods for using the proteins.
    Type: Grant
    Filed: May 31, 2023
    Date of Patent: February 25, 2025
    Assignee: Vaxxinova US, Inc.
    Inventors: Charles Nelson Carver, III, Daryll Emery
  • Polypeptides of fusobacterium and methods of use
    Patent number: 12178866
    Abstract: The present invention provides isolated polypeptides isolatable from a Fusobacterium spp. Also provided by the present invention are compositions that include one or more of the polypeptides, and methods for making and methods for using the polypeptides.
    Type: Grant
    Filed: May 8, 2023
    Date of Patent: December 31, 2024
    Assignee: Vaxxinova US, Inc.
    Inventors: Charles Nelson Carver, III, Daryll A. Emery
  • Polypeptides of and methods of use
    Patent number: 12171823
    Abstract: The present invention provides isolated polypeptides isolatable from a Fusobacterium spp. Also provided by the present invention are compositions that include one or more of the polypeptides, and methods for making and methods for using the polypeptides.
    Type: Grant
    Filed: August 16, 2022
    Date of Patent: December 24, 2024
    Assignee: Vaxxinova US, Inc.
    Inventors: Charles Nelson Carver, III, Daryll A. Emery